Novalead Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.74 Cr
- Paid Up Capital ₹ 0.18 M
- Company Age 17 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.34 Cr
- Revenue Growth 513.86%
- Profit Growth 353.23%
- Ebitda 53.09%
- Net Worth 17.90%
- Total Assets 18.52%
About Novalead Pharma
Novalead Pharma Private Limited (NPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 31 October 2007 and has a history of 17 years and three months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.74 Cr and a paid-up capital of Rs 0.18 M.
The company has closed loans amounting to ₹3.34 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vandan Agrawal, Supreet Kiran, Atul Aslekar, and Three other members serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100PN2007PTC130929
- Company No.
130929
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Oct 2007
- Date of AGM
24 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Novalead Pharma?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudhir Appaji  | Director | 17-Aug-2009 | Current |
| Girish Lakhe | Director | 17-Aug-2009 | Current |
| Atul Aslekar | Director | 31-Oct-2007 | Current |
| Vandan Agrawal | Nominee Director | 24-Nov-2022 | Current |
| Supreet Kiran | Director | 31-Oct-2007 | Current |
| Sankara Sankarasubramanian | Nominee Director | 24-Nov-2022 | Current |
Financial Performance of Novalead Pharma.
Novalead Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 513.86% increase. The company also saw a substantial improvement in profitability, with a 353.23% increase in profit. The company's net worth Soared by an impressive increase of 17.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novalead Pharma?
In 2023, Novalead Pharma had a promoter holding of 42.79% and a public holding of 57.21%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chellaram Shipping Private LimitedVandan Agrawal and Sankara Sankarasubramanian are mutual person
Chellaram FoundationVandan Agrawal and Sankara Sankarasubramanian are mutual person
Kishinchand Chellaram (India) Private LimitedVandan Agrawal and Sankara Sankarasubramanian are mutual person
- Lokumal Kishinchand Exports Private Limited
Vandan Agrawal and Sankara Sankarasubramanian are mutual person
- Boxmoor Shipping Private Limited
Vandan Agrawal and Sankara Sankarasubramanian are mutual person
- Edney Enterprises Private Limited
Vandan Agrawal and Sankara Sankarasubramanian are mutual person
Charges (Loans)
₹0
₹3.34 Cr
Charges Breakdown by Lending Institutions
- Biotechnology Industry Research Assistance Council : 3.34 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jan 2011 | Biotechnology Industry Research Assistance Council | ₹3.34 Cr | Satisfied |
How Many Employees Work at Novalead Pharma?
Unlock and access historical data on people associated with Novalead Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novalead Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novalead Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
